- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04618562
Revival Active Program for Adolescents With Depression
October 31, 2020 updated by: Revival Active
Impact of Revival Active Program on Adolescents With Depression: A Pilot Study
Active play and sports has shown to be effective intervention in managing depression. Extending the support with Mind body therapy, Revival Active Program was designed as an early intervention for adolescents.
To measure the efficacy and feasibility of the community based revival active play intervention for adolescent depression, present pilot study was undertaken.
Study Overview
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rajasthan
-
Jaipur, Rajasthan, India
- Gyansanjeevani
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children diagnosed with depression as per the DSM IV-TR criteria
- Parents willing to give written informed consent
Exclusion Criteria:
- Physical limitation for active sports
- Co-morbid mental health diagnosis
- high risk of self harm/ suicide
- history of self harm or harming someone else
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Revival Active Program
Revival Program included supervised play group, twice a week followed by home practice.
|
Program comprised of physical activities, group play, mind games, reasoning and discussion on sleeted topics, breath work and relaxation techniques, 60 minutes all together.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression
Time Frame: Changes from baseline depression at 8-week
|
Children Depression Inventory-II was used to assess depression level
|
Changes from baseline depression at 8-week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-Efficacy for Children
Time Frame: Changes from baseline self -efficacy at 8-week
|
Emotional, social and academic self efficacy was assessed using Self-Efficacy Questionnaire for Children
|
Changes from baseline self -efficacy at 8-week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Sadhana Sharma, L.E.A.D
- Principal Investigator: Sahil Signal, NMP Medical Research Institute, India
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 3, 2020
Primary Completion (Actual)
September 6, 2020
Study Completion (Actual)
September 18, 2020
Study Registration Dates
First Submitted
October 28, 2020
First Submitted That Met QC Criteria
October 31, 2020
First Posted (Actual)
November 6, 2020
Study Record Updates
Last Update Posted (Actual)
November 6, 2020
Last Update Submitted That Met QC Criteria
October 31, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RAP/002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.